- Home
- MSM vs ACLX Comparison
MSM vs ACLX Comparison
Compare MSM & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSM
- ACLX
- Stock Information
- Founded
- MSM 1941
- ACLX 2015
- Country
- MSM United States
- ACLX United States
- Employees
- MSM N/A
- ACLX N/A
- Industry
- MSM Industrial Machinery/Components
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- MSM Industrials
- ACLX Health Care
- Exchange
- MSM Nasdaq
- ACLX Nasdaq
- Market Cap
- MSM 5.1B
- ACLX 4.4B
- IPO Year
- MSM 1995
- ACLX 2022
- Fundamental
- Price
- MSM $86.98
- ACLX $87.33
- Analyst Decision
- MSM Hold
- ACLX Strong Buy
- Analyst Count
- MSM 5
- ACLX 13
- Target Price
- MSM $89.50
- ACLX $112.69
- AVG Volume (30 Days)
- MSM 521.4K
- ACLX 543.6K
- Earning Date
- MSM 10-23-2025
- ACLX 11-06-2025
- Dividend Yield
- MSM 3.91%
- ACLX N/A
- EPS Growth
- MSM N/A
- ACLX N/A
- EPS
- MSM 3.54
- ACLX N/A
- Revenue
- MSM $3,743,630,000.00
- ACLX $56,979,000.00
- Revenue This Year
- MSM N/A
- ACLX N/A
- Revenue Next Year
- MSM $4.38
- ACLX $210.73
- P/E Ratio
- MSM $24.57
- ACLX N/A
- Revenue Growth
- MSM N/A
- ACLX N/A
- 52 Week Low
- MSM $68.10
- ACLX $47.86
- 52 Week High
- MSM $94.31
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- MSM 39.99
- ACLX 69.86
- Support Level
- MSM $86.93
- ACLX $83.33
- Resistance Level
- MSM $92.93
- ACLX $90.41
- Average True Range (ATR)
- MSM 2.03
- ACLX 3.21
- MACD
- MSM -0.70
- ACLX 0.29
- Stochastic Oscillator
- MSM 29.70
- ACLX 77.66
About MSM MSC Industrial Direct Company Inc.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations (MRO) supplies. MSC primarily operates within North America where it derives over 95% of its revenue.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.